These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Prevention of colitis by interleukin 10-transduced T lymphocytes in the SCID mice transfer model. Van Montfrans C; Rodriguez Pena MS; Pronk I; Ten Kate FJ; Te Velde AA; Van Deventer SJ Gastroenterology; 2002 Dec; 123(6):1865-76. PubMed ID: 12454844 [TBL] [Abstract][Full Text] [Related]
6. Preventive effects of Schistosoma japonicum ova on trinitrobenzenesulfonic acid-induced colitis and bacterial translocation in mice. Zhao Y; Zhang S; Jiang L; Jiang J; Liu H J Gastroenterol Hepatol; 2009 Nov; 24(11):1775-80. PubMed ID: 20136961 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease. Abad C; Martinez C; Juarranz MG; Arranz A; Leceta J; Delgado M; Gomariz RP Gastroenterology; 2003 Apr; 124(4):961-71. PubMed ID: 12671893 [TBL] [Abstract][Full Text] [Related]
9. The prevention and treatment of murine colitis using gene therapy with adenoviral vectors encoding IL-10. Lindsay JO; Ciesielski CJ; Scheinin T; Hodgson HJ; Brennan FM J Immunol; 2001 Jun; 166(12):7625-33. PubMed ID: 11390520 [TBL] [Abstract][Full Text] [Related]
10. Interleukin-6 genetic ablation protects from trinitrobenzene sulfonic acid-induced colitis in mice. Putative effect of antiinflammatory cytokines. Gay J; Kokkotou E; O'Brien M; Pothoulakis C; Karalis KP Neuroimmunomodulation; 2006; 13(2):114-21. PubMed ID: 17077645 [TBL] [Abstract][Full Text] [Related]
11. RDP58, a novel immunomodulatory peptide with anti-inflammatory effects. A pharmacological study in trinitrobenzene sulphonic acid colitis and Crohn disease. Bourreille A; Doubremelle M; de la Blétière DR; Segain JP; Toquet C; Buelow R; Galmiche JP Scand J Gastroenterol; 2003 May; 38(5):526-32. PubMed ID: 12795464 [TBL] [Abstract][Full Text] [Related]
12. Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12. Duchmann R; Schmitt E; Knolle P; Meyer zum Büschenfelde KH; Neurath M Eur J Immunol; 1996 Apr; 26(4):934-8. PubMed ID: 8625991 [TBL] [Abstract][Full Text] [Related]
13. Amelioration of immune-mediated experimental colitis: tolerance induction in the presence of preexisting immunity and surrogate antigen bystander effect. Gotsman I; Shlomai A; Alper R; Rabbani E; Engelhardt D; Ilan Y J Pharmacol Exp Ther; 2001 Jun; 297(3):926-32. PubMed ID: 11356912 [TBL] [Abstract][Full Text] [Related]
14. [Suppression of Schistosoma japonicum eggs on TNBS-induced colitis in mice]. Mo HM; Liu WQ; Lei JH; Cheng YL; Wang CZ; Li YL Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Oct; 25(5):381-4. PubMed ID: 18441989 [TBL] [Abstract][Full Text] [Related]
15. Prevention and treatment of colitis with Lactococcus lactis secreting the immunomodulatory Yersinia LcrV protein. Foligne B; Dessein R; Marceau M; Poiret S; Chamaillard M; Pot B; Simonet M; Daniel C Gastroenterology; 2007 Sep; 133(3):862-74. PubMed ID: 17678918 [TBL] [Abstract][Full Text] [Related]
16. Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of inflammatory bowel disease. Lee J; Lee EN; Kim EY; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Lee KW; Kwon GY; Joh JW; Kim SJ Immunol Lett; 2005 Nov; 101(2):210-6. PubMed ID: 16026855 [TBL] [Abstract][Full Text] [Related]
17. Redirection of regulatory T cells with predetermined specificity for the treatment of experimental colitis in mice. Elinav E; Waks T; Eshhar Z Gastroenterology; 2008 Jun; 134(7):2014-24. PubMed ID: 18424268 [TBL] [Abstract][Full Text] [Related]
18. A critical role of CD30 ligand/CD30 in controlling inflammatory bowel diseases in mice. Sun X; Somada S; Shibata K; Muta H; Yamada H; Yoshihara H; Honda K; Nakamura K; Takayanagi R; Tani K; Podack ER; Yoshikai Y Gastroenterology; 2008 Feb; 134(2):447-58. PubMed ID: 18242212 [TBL] [Abstract][Full Text] [Related]
19. Immunomodulation of experimental colitis: the role of NK1.1 liver lymphocytes and surrogate antigens--bystander effect. Shlomai A; Trop S; Gotsman I; Jurim O; Diment J; Alper R; Rabbani E; Engelhardt D; Ilan Y J Pathol; 2001 Nov; 195(4):498-507. PubMed ID: 11745683 [TBL] [Abstract][Full Text] [Related]
20. Attenuation of mouse acute colitis by naked hepatocyte growth factor gene transfer into the liver. Hanawa T; Suzuki K; Kawauchi Y; Takamura M; Yoneyama H; Han GD; Kawachi H; Shimizu F; Asakura H; Miyazaki J; Maruyama H; Aoyagi Y J Gene Med; 2006 May; 8(5):623-35. PubMed ID: 16479533 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]